To verify the hypothesis that intravenous frusemide reduces endolymphatic hydrops, as evaluated by three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging following intratympanic gadolinium administration.
Does the intravenous administration of frusemide reduce endolymphatic hydrops?
FIORINO, FRANCESCO;MATTELLINI, Barbara;MAZZOCCHIN, Luca;PIZZINI, Francesca
2016-01-01
Abstract
To verify the hypothesis that intravenous frusemide reduces endolymphatic hydrops, as evaluated by three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging following intratympanic gadolinium administration.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
FIorino_Pizzini2016.pdf
non disponibili
Licenza:
Accesso ristretto
Dimensione
179.74 kB
Formato
Adobe PDF
|
179.74 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
